Edit |   |
---|---|
Antigenic Specificity | CD22, Human (Epratuzumab biosimilar) |
Clone | Epratuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD22 Recombinant Antibody (Epratuzumab). Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE). |
Immunogen | n/a |
Other Names | Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab, Anti-Human CD22 Recombinant Antibody(Epratuzumab), 90Y-DOTA-hLL2, Antibody Drug Analogues, Monoclonal Antibody, YR1021, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 205923-57-5 |
Catalog # | YR1021 |
Price | please inquire |
Order / More Info | CD22, Human (Epratuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |